Altered AP-1, RUNX, and EGR chromatin dynamics drive human fibrotic lung disease
Annals of the Rheumatic Diseases · 2026-07 · 85 (7) · 1381-1395
DOI: 10.1016/j.ard.2025.12.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2026-07. Verfasst von Eleanor Valenzi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA, USA; Division of Rheumatology and Clinica…. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Pulmonary Fibrosis, Chromatin, Transcription Factor AP-1. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAMS NIH HHS, NHLBI NIH HHS, NIH HHS.
Abstract (Originalsprache)
OBJECTIVES: Pulmonary fibrosis can result from autoimmune, inflammatory, or idiopathic conditions, including systemic sclerosis-associated interstitial lung disease (SSc-ILD). Previous studies have implicated myofibroblasts and SPP1hi macrophages as drivers of fibrosis in lungs, as well as other tissues. Single-cell RNA-sequencing has delineated fibroblast and macrophage transcriptomes but provides limited insight into the transcriptional control of profibrotic gene programmes. METHODS: To determine the chromatin accessibility dynamics and transcription factors driving profibrotic gene programmes in human pulmonary fibrosis, we performed multiomic single-nucleus assay for transposase-accessible (ATAC)/RNA-sequencing on explanted SSc-ILD and control lungs. Using the neural network tool ChromBPNet, we analysed pseudobulk fibroblast and macrophage populations to infer transcription factor binding dynamics at single base-pair resolution. Hierarchical causal modelling for single-cell multiomics data (HALO), a novel algorithm developed to derive low-dimensional representations of sparse multiomics data, revealed transcription factor-regulatory element-gene networks. RESULTS: ChromBPNet inferred increased transcription factor binding to profibrotic genes, including CTHRC1 and ADAM12 in fibroblasts, and SPP1 and CCL18 in macrophages. SSc-ILD fibroblasts showed increased binding and enhancer activity by AP-1, RUNX, and EGR transcription factors to profibrotic genes, whereas macrophages displayed enhanced binding and activity of AP-1 and basic helix-loop-helix (bHLH)-ZIP transcription factors in genes regulating the SPP1hi phenotype. HALO confirmed AP-1, RUNX, and EGR activity controlling profibrotic gene programmes. CONCLUSIONS: These data provide comprehensive insights into the complexity of transcriptional control of SSc-ILD gene expression programmes and define specific AP-1, RUNX, and EGR enhancers in key myofibroblast marker genes CTHRC1 and ADAM12, and a bHLH-ZIP enhancer in SPP1hi macrophages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA, USA; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA. Electroni…
- Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA, USA.
- Center for Systems Immunology and Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
- Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA; Center for Systems Immunology and Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
- Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
- Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA; School of Medicine, Tsinghua University, Beijing, China.
Förderung
- NIAMS NIH HHS
- NHLBI NIH HHS
- NIH HHS
- National Institutes of Health
- National Heart Lung and Blood Institute
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- University of Pittsburgh
- Francis Family Foundation
Zitieren
APA
Valenzi, E., Jia, M., Gerges, P., Fan, J., Tabib, T., Behera, R., Mao, H., Xue, D., Ju, E. M., Zhou, Y., Sembrat, J. C., Das, J., Benos, P. V., Singh, H., & Lafyatis, R. (2026). Altered AP-1, RUNX, and EGR chromatin dynamics drive human fibrotic lung disease. Annals of the Rheumatic Diseases, 85(7), 1381-1395. https://doi.org/10.1016/j.ard.2025.12.003
Vancouver
Valenzi E, Jia M, Gerges P, Fan J, Tabib T, Behera R, et al. Altered AP-1, RUNX, and EGR chromatin dynamics drive human fibrotic lung disease. Annals of the Rheumatic Diseases. 2026;85(7):1381-1395. doi:10.1016/j.ard.2025.12.003
BibTeX
@article{Valenzi2026,
author = {Valenzi, Eleanor and Jia, Minxue and Gerges, Peter and Fan, Jingyu and Tabib, Tracy and Behera, Rithika and Mao, Haiyi and Xue, Dan and Ju, Eun Mi and Zhou, Yuechen and Sembrat, John C and Das, Jishnu and Benos, Panayiotis V and Singh, Harinder and Lafyatis, Robert},
title = {Altered AP-1, RUNX, and EGR chromatin dynamics drive human fibrotic lung disease},
journal = {Annals of the Rheumatic Diseases},
year = {2026},
volume = {85},
number = {7},
pages = {1381--1395},
doi = {10.1016/j.ard.2025.12.003}
}
EUVIMED